08:50 AM EST, 02/27/2025 (MT Newswires) -- NovoCure ( NVCR ) reported a Q4 net loss Thursday of $0.61 per diluted share, compared with a loss of $0.45 a year earlier.

Analysts surveyed by FactSet expected a loss of $0.34.

Revenue for the quarter ended Dec. 31 was $161.3 million, compared with $133.8 million a year earlier. Four analysts surveyed by FactSet expected $161.3 million.

NVCR shares were 0.4% lower in recent premarket activity.